Mitochondrial Dysfunction as a Therapeutic Target in Diabetic Cardiomyopathy: Progress and Prospects
Diabetic cardiomyopathy (DCM) is a specific type of cardiomyopathy that is independent of hypertension and coronary artery disease, and is closely associated with the high incidence and mortality of heart failure in people with diabetes. DCM causes microvascular disease, myocardial metabolic disorde...
Saved in:
Main Authors: | Feng Zhang, Zhuqing Li, Yanxin Wang, Chao Li, Chengzhi Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2025-01-01
|
Series: | Cardiovascular Innovations and Applications |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2024.0063 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peripheral mitochondrial transplantation alleviates diabetes-associated cognitive dysfunction by suppressing cuproptosis
by: Juan Hu, et al.
Published: (2025-03-01) -
Editorial: Revealing the role of mitochondrial gene defects in tumor progression and developing mitochondrial-targeted drugs
by: Leilei Liang, et al.
Published: (2025-02-01) -
Targeted therapeutic strategies for Nectin-4 in breast cancer: Recent advances and future prospects
by: Yufei Wang, et al.
Published: (2025-02-01) -
Identification of mitochondrial carrier homolog 2 as an important therapeutic target of castration-resistant prostate cancer
by: Yankui Liu, et al.
Published: (2025-02-01) -
TAB2 deficiency induces dilated cardiomyopathy by promoting mitochondrial calcium overload in human iPSC-derived cardiomyocytes
by: Wenrui Sun, et al.
Published: (2025-02-01)